find the latest legal job
Corporate and Commercial Partner
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Full time · Join a leading Adelaide commercial law firm
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Sydney NSW
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Melbourne VIC
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
Legal Inhouse / Lawyer / Company Secretary
Category: Other | Location: Brisbane QLD 4000
· Fantastic Company · Potential to be Part Time / Flexible Work Pattern
View details
Part Time Risk & Compliance Officer
Category: Other | Location: Brisbane QLD 4000
· Brisbane City · Flexible Part Time Hours
View details
ABL advises on biotech deal

ABL advises on biotech deal

Arnold Bloch Leibler has advised biotechnology firm Acrux in an exclusive worldwide licensing agreement with US pharmaceutical giant, Eli Lilly.

ARNOLD Bloch Leibler has advised biotechnology firm Acrux in an exclusive worldwide licensing agreement with US pharmaceutical giant, Eli Lilly.

The terms of the agreement, which is potentially worth up to US$335 million, will give Eli Lilly the rights to market Acrux’s new product,Axiron, an underarm testosterone solution for the treatment of testosterone deficiency in men.

Arnold Bloch Leibler partner Jane Sheridan lead the deal, with lawyer Amanda Hutchings.

Under the deal, Acrux will receive an up-front payment of US$50 million, plus US$3 million for the manufacturing assets.

Acrux will also receive a further US$87 million upon the US Food and Drug Administration’s approval to market Axiron. If successfully commercialised, Acrux will receive up to US$195 million in potential commercialisation milestones, as well as royalty payments on future global sales.

Eli Lilly has a sales, marketing and distribution capability covering 143 countries.

Acrux’s chairman, Ross Dobinson, said he believes this is the largest licensing deal ever struck by an Australian biotech company.



Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

ABL advises on biotech deal
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
LCA welcomes religious freedom panel
06:04
LCA welcomes religious freedom panel
The Law Council of Australia says the establishment of a panel which will examine the human right to...
Law Society launched a new website, legal politics and lawmaking
06:00
Law Society launches project to engage young Aussies
The Law Society of NSW has launched a new website to engage young Australians in legal politics and ...
recognised for human rights work
06:00
LexisNexis executive recognised for human rights work
A LexisNexis executive has been announced as a finalist in a global awards program for women in busi...
APPOINTMENTS
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
opinion
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
Help
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...